Corbus Pharmaceuticals Holdings Inc [CRBP] stock is trading at $20.92, down -2.65%. An important factor to consider is whether the stock is rising or falling in short-term value. The CRBP shares have gain 7.23% over the last week, with a monthly amount drifted -62.56%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Corbus Pharmaceuticals Holdings Inc [NASDAQ: CRBP] stock has seen the most recent analyst activity on July 30, 2024, when Wedbush initiated its Outperform rating and assigned the stock a price target of $85. On June 26, 2024, B. Riley Securities initiated with a Buy rating and assigned a price target of $85 on the stock. Oppenheimer reiterated its Outperform rating and increased its price target to $80 on June 03, 2024. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $77 as its price target on May 13, 2024. Jefferies upgraded its rating to Buy for this stock on March 06, 2024, and upped its price target to $46. In a note dated September 08, 2020, ROTH Capital downgraded an Neutral rating on this stock and revised its target price from $40 to $3.
Corbus Pharmaceuticals Holdings Inc [CRBP] stock has fluctuated between $3.03 and $61.90 over the past year. Currently, Wall Street analysts expect the stock to reach $68.33 within the next 12 months. Corbus Pharmaceuticals Holdings Inc [NASDAQ: CRBP] shares were valued at $20.92 at the most recent close of the market. An investor can expect a potential return of 226.63% based on the average CRBP price forecast.
Analyzing the CRBP fundamentals
Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -29.78%, Pretax Profit Margin comes in at -25.91%, and Net Profit Margin reading is -25.91%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -0.65 and Total Capital is -0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 20.41 points at the first support level, and at 19.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 21.82, and for the 2nd resistance point, it is at 22.71.
Ratios To Look Out For
For context, Corbus Pharmaceuticals Holdings Inc’s Current Ratio is 6.18. On the other hand, the Quick Ratio is 6.18, and the Cash Ratio is 1.0.
Transactions by insiders
Recent insider trading involved Cormorant Asset Management, LP, 10% Owner, that happened on Sep 20 ’24 when 0.35 million shares were purchased. Director, CATLIN AVERY W completed a deal on Sep 04 ’24 to buy 888.0 shares. Meanwhile, Chief Financial Officer Moran Sean F. sold 9355.0 shares on Jun 14 ’24.
